StockTipsArenaBeta

BUY Krsnaa Diagnostics Limited — Systematix Shares & Stock

BUYKrsnaa Diagnostics Limited
Krsnaa Diagnostics share price target & all analyst calls

bySystematix Shares & StockHorizon: NA (inferred 1 year)7 Jul 2026via Economic Times Stock Recos Overview

Entry₹550Inferred
Target₹833
Total upside +51.45%
Stop lossNot given
CMP₹512.35Just now
Active-6.85%+62.58%upside left 9 mo left
Follow Systematix Shares & Stock for new callsGet alertsWatch KRSNAA for new buy/sell callsGet alertsSee 198 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 11:42 am IST
9 supporting4 neutral1 opposing
Supports the BUY call (9)

Krsnaa Diagnostics has entered a strategic collaboration with AZmed to integrate AI technology into its radiology reporting, aiming to improve efficiency and support scalable growth.

NSE · Press Release·22 Oct · today

(opens in new tab)

Krsnaa Diagnostics has announced a strategic collaboration with AZmed to implement AI solutions in radiology, targeting enhanced operational efficiency and growth.

BSE · Company Update·22 Oct · today

(opens in new tab)

Krsnaa Diagnostics to sell diagnostic equipment worth up to ₹120 crore

NewsCnbc-Tv18·28 Sept · 3w ago

(opens in new tab)
Neutral / worth noting (4)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·21 Oct · yesterday

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Krsnaa Diagnostics

All analyst calls on Krsnaa Diagnostics

More from Systematix Shares & Stock

Every call and its outcome